David Gonzalez de Castro

David Gonzalez de Castro is Professor of Genomic Medicine at Queen's University Belfast's School of Medicine, Dentistry and Biomedical Sciences. He leads the Genomics and Bioinformatics teams at the Precision Medicine Centre, where his research focuses on developing genomic stratification tools for precision oncology. Previously, he served as Clinical Scientist at The Royal Marsden Hospital and Institute of Cancer Research (2004-2016), where he led the Molecular Diagnostics Laboratory.

His research explores:

• Molecular biomarkers for hematological/solid tumors
• Genomic stratification for personalized cancer treatment
• Translational applications of next-generation sequencing
• Development of clinical diagnostic platforms
• Bioinformatics approaches for cancer classification

Recent publications demonstrate focus on:

• Lymphoma genomics and subtyping
• Validation of molecular diagnostic platforms
• Liquid biopsy applications
• Implementation of population-based cancer testing

He leads significant projects including:

• 'KaryoSequencing: clinical diagnosis of genomic aberrations in myeloid disorders' (PI, 2020-2022)
• 'Precision Medicine Catapult Centre of Excellence' (Co-Investigator, 2017-present)

Hosts academic visitors and collaborates internationally on cancer genomics initiatives.